{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:51:38Z","timestamp":1790247098723,"version":"4.1.0"},"reference-count":39,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Cases"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>Low-molecular-weight heparins (LMWH) are the most commonly used anticoagulants during pregnancy. It is considered to be the drug of choice due to its safety in not crossing placenta. Considering the beneficial effect in the improvement of microcirculation, prophylactic application of LMWH in patients with preeclampsia became a trend. However, the bleeding risk related with LMWH in preeclampsia patients has seldomly been evaluated. This current study aimed to identify the potential risks regarding LMWH application in patients with preeclampsia.<\/jats:p>\n          <jats:p>CASE SUMMARY<\/jats:p>\n          <jats:p>Herein we present a case series of three pregnant women diagnosed with preeclampsia on LMWH therapy during pregnancy. All the cases experienced catastrophic hemorrhagic events. After reviewing the twenty-one meta-analyses, the bleeding risk related with LMWH seems ignorable. Only one study analyzed the bleeding risk of LMWH and found a significantly higher risk of developing PPH in women receiving LMWH. Other studies reported minor bleeding risks, none of these were serious enough to stop LMWH treatment. Possibilities of bleeding either from uterus or from intrabdominal organs in preeclampsia patients on LMWH therapy should not be ignored. Intensive management of blood pressure even after delivery and homeostasis suture in surgery are crucial.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>Consideration should be given to the balance between benefits and risks of LMWH in patients with preeclampsia.<\/jats:p>","DOI":"10.12998\/wjcc.v12.i9.1634","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T04:19:08Z","timestamp":1711340348000},"page":"1634-1643","source":"Crossref","is-referenced-by-count":2,"title":["Low-molecular-weight heparin and preeclampsia \u2014 does the sword cut both ways? Three case reports and review of literature"],"prefix":"10.12998","volume":"12","author":[{"given":"Dan","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.04.032"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002706"},{"key":"B3","unstructured":"Queensland Clinical Guidelines.   Venous thromboembolism (VTE) in pregnancy and the puerperium. Guideline MN20.9-V6-R25. Queensland Health. 2020. Available from: http:\/\/www.health.qld.gov.au\/qcg"},{"key":"B4","unstructured":"Royal College of Obstetricians and Gynaecologists.   Reducing the risk of thrombosis and embolism during pregnancy and the puerperium (green-top guideline No.37a). 2015: 1-40. Available from: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/reducing-the-risk-of-thrombosis-and-embolism-during-pregnancy-and-the-puerperium-green-top-guideline-no-37a\/"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000291"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.11.006"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02609-4"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1608433"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2020.11.001"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000000704"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024802"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1446209"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1939299"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2019.e00169"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3782-2"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2164"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20200042"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101974"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012852.pub2"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101935"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01124-z"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13219"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1404979"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1160\/th16-02-0169"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001689.pub4"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15789"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31139-4"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1419179"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1543656"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.10.036"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13359"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2022.10.010"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003018"},{"key":"B34","unstructured":"National Institute for Health and Care Excellence: Guidelines.   In Hypertension in pregnancy: diagnosis and management. London. 2019. Available from: https:\/\/www.nice.org.uk\/guidance\/ng133"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12399"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004251"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/uog.22134"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.05.010"},{"key":"B39","unstructured":"Royal College of Obstetricians and Gynaecologists.   The Investigation and Management of the Small\u2013for\u2013Gestational\u2013Age Fetus. Green-top guideline No. 31. RCOG 2014. Available from: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/small-for-gestational-age-fetus-investigation-and-management-green-top-guideline-no-31\/"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i9\/1634.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i9\/1634.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T04:19:47Z","timestamp":1711340387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i9\/1634.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":39,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v12.i9.1634","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}